These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9159305)

  • 21. Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1994; 68(4):437-41. PubMed ID: 7870228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct measurement of nitric oxide concentration in CAPD dialysate.
    Mochizuki S; Takayama A; Sasaki T; Horike H; Kashihara N; Ogasawara Y; Kajiya F; Kitawaki T; Oka H
    Perit Dial Int; 2009; 29(1):111-4. PubMed ID: 19164261
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation.
    Bastani B; Chu N
    Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of malnourished CAPD patients with an amino acid based dialysate.
    Kopple JD; Bernard D; Messana J; Swartz R; Bergström J; Lindholm B; Lim V; Brunori G; Leiserowitz M; Bier DM
    Kidney Int; 1995 Apr; 47(4):1148-57. PubMed ID: 7783413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of 1.1% amino acid dialysis solution in hypoalbuminemic continuous ambulatory peritoneal dialysis patients.
    Taylor GS; Patel V; Spencer S; Fluck RJ; McIntyre CW
    Clin Nephrol; 2002 Dec; 58(6):445-50. PubMed ID: 12508967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis.
    Ferrier ML; Combet S; van Landschoot M; Stoenoiu MS; Cnops Y; Lameire N; Devuyst O
    Kidney Int; 2001 Dec; 60(6):2343-50. PubMed ID: 11737609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
    Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of culture isolates from peritoneal dialysis peritonitis patients in southern India using an automated blood culture system to culture peritoneal dialysate.
    Gupta S; Muralidharan S; Gokulnath ; Srinivasa H
    Nephrology (Carlton); 2011 Jan; 16(1):63-7. PubMed ID: 21175980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
    Arfeen S; Goodship TH; Kirkwood A; Ward MK
    Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
    Kim DH; Yang DH; Hong SY
    Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis.
    Kopple JD; Blumenkrantz MJ; Jones MR; Moran JK; Coburn JW
    Am J Clin Nutr; 1982 Sep; 36(3):395-402. PubMed ID: 7113946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Netilmicin in the treatment of clinical peritonitis in chronic renal failure patients managed by continuous ambulatory peritoneal dialysis.
    Neale TJ; Malani J; Humble M
    N Z Med J; 1987 Jun; 100(826):374-7. PubMed ID: 3451106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
    da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
    Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Yang LY; Chen A; Huang TP
    Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study.
    Ndlovu KC; Sibanda W; Assounga A
    BMC Nephrol; 2017 Feb; 18(1):48. PubMed ID: 28158991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis.
    Schmidt RJ; Yokota S; Tracy TS; Sorkin MI; Baylis C
    Am J Physiol; 1999 May; 276(5):F794-7. PubMed ID: 10330062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.